[Effect of streptase, traskolan and sefril on experimental osteitis. II. Morphological changes in the internal organs].
D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D007611:Aprotinin / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D002515:Cephradine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005269:Femur / Q000473:pathology; D007263:Infusions, Parenteral; D008297:Male; D010000:Osteitis / Q000188:drug therapy / Q000473:pathology*; D011817:Rabbits; D013300:Streptokinase / Q000008:administration & dosage
D000890:Anti-Infective Agents; D002511:Cephalosporins; D007611:Aprotinin; D013300:Streptokinase; D002515:Cephradine
Wpływ streptazy, traskolanu i sefrilu na rozwoj doswiadczalnego zapalenia kości.